Gujarat Terce Laboratories Limited has announced the re-appointment of Mr. Aalap Prajapati as Managing Director & Chief Executive Officer. This decision was approved by the company’s members at the 41st Annual General Meeting held on Friday, 21 August 2026. Mr. Prajapati will serve a term of three consecutive years, commencing from 28 October 2026 to 27 October 2029. He brings over 15 years of experience in the pharmaceutical and healthcare sectors.
Leadership Continuity for Gujarat Terce Laboratories
Gujarat Terce Laboratories Limited has secured continuity in its top leadership with the re-appointment of Mr. Aalap Prajapati as the Managing Director and Chief Executive Officer (CEO). The approval for his reappointment was granted by the company’s shareholders during the 41st Annual General Meeting, which took place on Friday, 21 August 2026.
Extended Tenure and Key Responsibilities
Mr. Prajapati’s renewed mandate will be for a period of three consecutive years. His new term as Managing Director & CEO is set to commence on 28 October 2026 and will conclude on 27 October 2029. This extension underscores the confidence placed in his leadership and strategic vision for the company.
Executive Profile and Experience
With over 15 years of experience in the pharmaceutical and healthcare industry, Mr. Aalap Prajapati has been instrumental in driving the company’s growth initiatives. His expertise spans business strategy, operations management, marketing, and business development. He holds a management qualification from the B.K. School of Business Management, specializing in Marketing and Operations. Mr. Prajapati is the son of Mr. Natwarbhai Prajapati, a Whole-Time Director of the company. He is not currently debarred from holding a director’s office by any regulatory authority.
Source: BSE
